Lactum Pharma Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
- Paid Up Capital ₹ 7.50 M
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.20 Cr
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 0.04%
About Lactum Pharma
Lactum Pharma Private Limited (LPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 November 2006 and has a history of 18 years and two months. Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.50 M.
The company currently has active open charges totaling ₹2.20 Cr.
Harshad Khachane and Sachin Gaike serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239MH2006PTC165707
-
Company No.
165707
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Nov 2006
-
Date of AGM
30 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Lactum Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harshad Khachane
|
Director | 22-Nov-2006 | Current |
|
Sachin Gaike
|
Director | 22-Nov-2006 | Current |
Financial Performance of Lactum Pharma.
Lactum Pharma Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lactum Pharma?
In 2018, Lactum Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Harsh Vaibhav Chem Pharma Private LimitedHarshad Khachane is a mutual person
-
Khachane Engineering Pvt Ltd
Harshad Khachane is a mutual person
-
Madhura Die Cast Private Limited
Sachin Gaike is a mutual person
Charges (Loans)
₹22.00 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 2.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2013 | Indian Overseas Bank | ₹2.20 Cr | Open |
How Many Employees Work at Lactum Pharma?
Unlock and access historical data on people associated with Lactum Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lactum Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lactum Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
